166 related articles for article (PubMed ID: 30222231)
1. The Action of the Hexokinase Inhibitor 2-deoxy-d-glucose on Cryptosporidium parvum and the Discovery of Activities against the Parasite Hexokinase from Marketed Drugs.
Eltahan R; Guo F; Zhang H; Zhu G
J Eukaryot Microbiol; 2019 May; 66(3):460-468. PubMed ID: 30222231
[TBL] [Abstract][Full Text] [Related]
2. A unique hexokinase in Cryptosporidium parvum, an apicomplexan pathogen lacking the Krebs cycle and oxidative phosphorylation.
Yu Y; Zhang H; Guo F; Sun M; Zhu G
Protist; 2014 Sep; 165(5):701-14. PubMed ID: 25216472
[TBL] [Abstract][Full Text] [Related]
3. Discovery of ebselen as an inhibitor of Cryptosporidium parvum glucose-6-phosphate isomerase (CpGPI) by high-throughput screening of existing drugs.
Eltahan R; Guo F; Zhang H; Xiang L; Zhu G
Int J Parasitol Drugs Drug Resist; 2018 Apr; 8(1):43-49. PubMed ID: 29414105
[TBL] [Abstract][Full Text] [Related]
4. The inhibition of bovine heart hexokinase by 2-deoxy-D-glucose-6-phosphate: characterization by 31P NMR and metabolic implications.
Chen W; Guéron M
Biochimie; 1992; 74(9-10):867-73. PubMed ID: 1467345
[TBL] [Abstract][Full Text] [Related]
5. Novel lactate dehydrogenase inhibitors with in vivo efficacy against Cryptosporidium parvum.
Li K; Nader SM; Zhang X; Ray BC; Kim CY; Das A; Witola WH
PLoS Pathog; 2019 Jul; 15(7):e1007953. PubMed ID: 31356619
[TBL] [Abstract][Full Text] [Related]
6. 5-Aminopyrazole-4-Carboxamide-Based Compounds Prevent the Growth of Cryptosporidium parvum.
Huang W; Choi R; Hulverson MA; Zhang Z; McCloskey MC; Schaefer DA; Whitman GR; Barrett LK; Vidadala RSR; Riggs MW; Maly DJ; Van Voorhis WC; Ojo KK; Fan E
Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28533246
[No Abstract] [Full Text] [Related]
7. Inhibition of Calcium-Dependent Protein Kinase 1 (CDPK1) In Vitro by Pyrazolopyrimidine Derivatives Does Not Correlate with Sensitivity of Cryptosporidium parvum Growth in Cell Culture.
Kuhlenschmidt TB; Rutaganira FU; Long S; Tang K; Shokat KM; Kuhlenschmidt MS; Sibley LD
Antimicrob Agents Chemother; 2016 Jan; 60(1):570-9. PubMed ID: 26552986
[TBL] [Abstract][Full Text] [Related]
8. Multiple pathways for glucose phosphate transport and utilization support growth of Cryptosporidium parvum.
Xu R; Beatty WL; Greigert V; Witola WH; Sibley LD
Nat Commun; 2024 Jan; 15(1):380. PubMed ID: 38191884
[TBL] [Abstract][Full Text] [Related]
9. A screening pipeline for antiparasitic agents targeting cryptosporidium inosine monophosphate dehydrogenase.
Sharling L; Liu X; Gollapalli DR; Maurya SK; Hedstrom L; Striepen B
PLoS Negl Trop Dis; 2010 Aug; 4(8):e794. PubMed ID: 20706578
[TBL] [Abstract][Full Text] [Related]
10. Isoenzyme activities of different strains of Cryptosporidium parvum.
El-Ghaysh A; Barrett J
Vet Parasitol; 1999 Mar; 81(3):195-200. PubMed ID: 10190863
[TBL] [Abstract][Full Text] [Related]
11. A cysteine protease inhibitor rescues mice from a lethal Cryptosporidium parvum infection.
Ndao M; Nath-Chowdhury M; Sajid M; Marcus V; Mashiyama ST; Sakanari J; Chow E; Mackey Z; Land KM; Jacobson MP; Kalyanaraman C; McKerrow JH; Arrowood MJ; Caffrey CR
Antimicrob Agents Chemother; 2013 Dec; 57(12):6063-73. PubMed ID: 24060869
[TBL] [Abstract][Full Text] [Related]
12. A novel calcium-dependent protein kinase inhibitor as a lead compound for treating cryptosporidiosis.
Castellanos-Gonzalez A; White AC; Ojo KK; Vidadala RS; Zhang Z; Reid MC; Fox AM; Keyloun KR; Rivas K; Irani A; Dann SM; Fan E; Maly DJ; Van Voorhis WC
J Infect Dis; 2013 Oct; 208(8):1342-8. PubMed ID: 23878324
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of chitosan, a natural polysaccharide, against Cryptosporidium parvum in vitro and in vivo in neonatal mice.
Mammeri M; Chevillot A; Thomas M; Polack B; Julien C; Marden JP; Auclair E; Vallée I; Adjou KT
Exp Parasitol; 2018 Nov; 194():1-8. PubMed ID: 30237052
[TBL] [Abstract][Full Text] [Related]
14. Defining Stage-Specific Activity of Potent New Inhibitors of Cryptosporidium parvum Growth
Funkhouser-Jones LJ; Ravindran S; Sibley LD
mBio; 2020 Mar; 11(2):. PubMed ID: 32127445
[No Abstract] [Full Text] [Related]
15. Differentiation between human and animal strains of Cryptosporidium parvum using isoenzyme typing.
Awad-el-Kariem FM; Robinson HA; Dyson DA; Evans D; Wright S; Fox MT; McDonald V
Parasitology; 1995 Feb; 110 ( Pt 2)():129-32. PubMed ID: 7885731
[TBL] [Abstract][Full Text] [Related]
16. 2-Deoxy-d-Glucose and Its Analogs: From Diagnostic to Therapeutic Agents.
Pajak B; Siwiak E; Sołtyka M; Priebe A; Zieliński R; Fokt I; Ziemniak M; Jaśkiewicz A; Borowski R; Domoradzki T; Priebe W
Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31905745
[TBL] [Abstract][Full Text] [Related]
17. Identification of Cryptosporidium parvum active chemical series by Repurposing the open access malaria box.
Bessoff K; Spangenberg T; Foderaro JE; Jumani RS; Ward GE; Huston CD
Antimicrob Agents Chemother; 2014 May; 58(5):2731-9. PubMed ID: 24566188
[TBL] [Abstract][Full Text] [Related]
18. Novel anti-Cryptosporidium activity of known drugs identified by high-throughput screening against parasite fatty acyl-CoA binding protein (ACBP).
Fritzler JM; Zhu G
J Antimicrob Chemother; 2012 Mar; 67(3):609-17. PubMed ID: 22167242
[TBL] [Abstract][Full Text] [Related]
19. 2-Deoxy-D-glucose uptake in cultured human muscle cells.
Jacobs AE; Oosterhof A; Veerkamp JH
Biochim Biophys Acta; 1990 Mar; 1051(3):230-6. PubMed ID: 2310773
[TBL] [Abstract][Full Text] [Related]
20. A high-throughput phenotypic screen identifies clofazimine as a potential treatment for cryptosporidiosis.
Love MS; Beasley FC; Jumani RS; Wright TM; Chatterjee AK; Huston CD; Schultz PG; McNamara CW
PLoS Negl Trop Dis; 2017 Feb; 11(2):e0005373. PubMed ID: 28158186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
